Biomarkers Predicting a Need for Intensive Treatment in Patients with Early Arthritis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|2|170-181

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.2, 2015-01, pp. : 170-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment strategies for early psoriatic arthritis

By Olivieri Ignazio   D'Angelo Salvatore   Palazzi Carlo   Padula Angela  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 271-282

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab a PREMIER treatment for early rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Biomarkers predicting treatment outcome in depression: what is clinically significant?

By Uher Rudolf   Tansey Katherine E   Malki Karim   Perlis Roy H  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 233-240

Future Medicine

Access to resources Recommend Favorite

Strategies for the Prevention and Treatment of Osteoporosis in Patients with Rheumatoid Arthritis

By Phillips Kristine   Aliprantis Antonios   Coblyn Jonathan  

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 773-779

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH   Toonen Erik JM   Scheffer Hans   Radstake Timothy RDJ   Barrera Pilar   Franke Barbara  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite